NEW YORK (GenomeWeb) – Singlera Genomics said today that it has raised $60 million in Series A+ financing led by Green Pine Capital Partners and Prosperico Ventures.

La Jolla, California- and Shanghai-based Singlera said that it will use the funds to help expand the development and commercialization of its non-invasive genetic tests for early-stage cancer detection and to fund clinical validation studies. The firm said that it will also use the funds to further expand its research facilities and its TitanSeq and Monod platforms into new product lines.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.